Cardiovascular Pharmacology: Heart and circulation :Heart and circulation ( Volume 59 )

Publication subTitle :Heart and circulation

Publication series :Volume 59

Author: Vanhoutte   Paul  

Publisher: Elsevier Science‎

Publication year: 2010

E-ISBN: 9780123849045

P-ISBN(Paperback): 9780123849038

P-ISBN(Hardback):  9780123849038

Subject: R3 Basic Medical;R9 Pharmacy

Language: ENG

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Description

Cardiovascular disease remains a major cause of death and disability in developed countries and, increasingly so, in the developing world. Presented in this volume of Advances in Pharmacology are some of the most promising possibilities for treating large numbers of individuals afflicted with these conditions.

  • Contains up-to-date reviews of the most important emerging cardiovascular therapies written by world leaders in the field

Chapter

Cover

pp.:  1 – 2

Contents

pp.:  6 – 10

Contributors

pp.:  10 – 12

Foreword

pp.:  12 – 14

Neuregulin-1/ErbB Signaling and Chronic Heart Failure

pp.:  44 – 66

If Inhibition in Cardiovascular Diseases

pp.:  66 – 106

Pharmacology of Cardiac Potassium Channels

pp.:  106 – 148

Beta3-Adrenergic Receptors in Cardiacand Vascular Tissues: Emerging Conceptsand Therapeutic Perspectives

pp.:  148 – 178

Modulation of Vascular Sarco/Endoplasmic Reticulum Calcium ATPase in Cardiovascular Pathophysiology

pp.:  178 – 210

Advances in the Renin Angiotensin System: Focus on Angiotensin-Converting Enzyme 2 and Angiotensin-(1–7)

pp.:  210 – 248

The Role of Calpain in Diabetes-Associated Platelet Hyperactivation

pp.:  248 – 272

Tissue Factor in Cardiovascular Disease: Pathophysiology and Pharmacological Intervention

pp.:  272 – 306

Index

pp.:  306 – 324

Contents of Previous Volumes

pp.:  324 – 346

The users who browse this book also browse


No browse record.